1. Home
  2. MRSN vs DTST Comparison

MRSN vs DTST Comparison

Compare MRSN & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • DTST
  • Stock Information
  • Founded
  • MRSN 2001
  • DTST 2001
  • Country
  • MRSN United States
  • DTST United States
  • Employees
  • MRSN N/A
  • DTST N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • DTST EDP Services
  • Sector
  • MRSN Health Care
  • DTST Technology
  • Exchange
  • MRSN Nasdaq
  • DTST Nasdaq
  • Market Cap
  • MRSN 37.0M
  • DTST 32.6M
  • IPO Year
  • MRSN 2017
  • DTST N/A
  • Fundamental
  • Price
  • MRSN $8.07
  • DTST $4.12
  • Analyst Decision
  • MRSN Strong Buy
  • DTST Hold
  • Analyst Count
  • MRSN 3
  • DTST 1
  • Target Price
  • MRSN $33.00
  • DTST N/A
  • AVG Volume (30 Days)
  • MRSN 41.5K
  • DTST 66.5K
  • Earning Date
  • MRSN 11-12-2025
  • DTST 11-13-2025
  • Dividend Yield
  • MRSN N/A
  • DTST N/A
  • EPS Growth
  • MRSN N/A
  • DTST N/A
  • EPS
  • MRSN N/A
  • DTST N/A
  • Revenue
  • MRSN $34,769,000.00
  • DTST $25,455,742.00
  • Revenue This Year
  • MRSN N/A
  • DTST $12.57
  • Revenue Next Year
  • MRSN N/A
  • DTST $9.29
  • P/E Ratio
  • MRSN N/A
  • DTST N/A
  • Revenue Growth
  • MRSN 16.14
  • DTST 0.53
  • 52 Week Low
  • MRSN $5.21
  • DTST $2.93
  • 52 Week High
  • MRSN $70.75
  • DTST $5.44
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 61.29
  • DTST 35.16
  • Support Level
  • MRSN $7.63
  • DTST $4.10
  • Resistance Level
  • MRSN $8.35
  • DTST $4.42
  • Average True Range (ATR)
  • MRSN 0.39
  • DTST 0.16
  • MACD
  • MRSN 0.01
  • DTST -0.02
  • Stochastic Oscillator
  • MRSN 72.97
  • DTST 6.67

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: